Eluxadoline

艾沙度林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEluxadoline
Drug Alias Nameeluxadolinum艾沙多林eluxadolina依鲁朵林Truberzi +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonistsδ-opioid receptor antagonistsKappa opioid receptor agonists
TargetsMu opioid receptorKappa opioid receptorδ-opioid receptor
Therapy Area/IndicationsDiarrheaConstipationDiabetes Mellitus +[6] 
Global Approved IndicationsDiarrheaConstipationIrritable Bowel Syndrome
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2015/05/27
Country/TerritoryBulgariaCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesActavisJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie Inc
Inactive CompaniesFuriex Pharmaceuticals IncAllergan Pharmaceuticals International LtdUniversity Of North Carolina At Chapel Hill +[4] 
Active IndicationsConstipationIrritable Bowel Syndrome
Inactive IndicationsDiarrheaDiabetes MellitusUrinary Incontinence, Urge +[4] 

Other Information

ATC CodeA07DA06
Related LinksWikipediaDrugBankKEGG